Medicover AB (0RPS) Financial Statements
Medicover AB Financial Overview
Medicover AB's market cap is currently $43.08B. The company's EPS TTM is $0.56; its P/E ratio is 45.87; and it has a dividend yield of 0.77%. Medicover AB is scheduled to report earnings on November 4, 2026, and the estimated EPS forecast is $1.84. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.38B | $ 2.09B | $ 1.75B | $ 1.51B | $ 1.38B |
| Gross Profit | $ 550.70M | $ 448.30M | $ 359.40M | $ 335.60M | $ 395.00M |
| Operating Income | $ 155.70M | $ 70.30M | $ 61.40M | $ 55.50M | $ 159.40M |
| EBITDA | $ 377.70M | $ 271.40M | $ 257.40M | $ 215.90M | $ 274.90M |
| Net Income | $ 77.50M | $ 16.70M | $ 17.60M | $ 11.80M | $ 101.80M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 88.20M | $ 82.80M | $ 64.40M | $ 49.10M | $ 277.90M |
| Total Assets | $ 2.42B | $ 2.14B | $ 1.94B | $ 1.83B | $ 1.68B |
| Total Debt | $ 1.44B | $ 1.24B | $ 1.00B | $ 940.00M | $ 764.60M |
| Net Debt | $ 1.36B | $ 1.17B | $ 952.90M | $ 899.60M | $ 682.70M |
| Total Liabilities | $ 1.88B | $ 1.65B | $ 1.41B | $ 1.32B | $ 1.12B |
| Stockholders' Equity | $ 532.80M | $ 464.80M | $ 496.50M | $ 474.70M | $ 517.60M |
| Cash Flow | |||||
| Free Cash Flow | $ 185.60M | $ 139.60M | $ 94.50M | $ 29.60M | $ 114.50M |
| Operating Cash Flow | $ 343.70M | $ 261.90M | $ 205.00M | $ 170.20M | $ 216.70M |
| Investing Cash Flow | $ -322.10M | $ -134.70M | $ -119.80M | $ -184.80M | $ -333.60M |
| Financing Cash Flow | $ -5.80M | $ -108.00M | $ -73.70M | $ -24.30M | $ 164.10M |
Currency in EUR